Single-arm studies set the pace of oncology
Interviewee/Contributor
Bruno Pagliara
Organisation
On-kòs Pharma Consulting
Research Directory
Partial recovery of biotechs
Interviewee/ContributorWilliam EllingtonOrganisationMedNousThe shift towards value-based pricing for medicines
Interviewee/ContributorVictoria EnglishOrganisationMedNousNCI and industry: Moving innovations from the lab to patients
Interviewee/ContributorMichael Salgaller and Michele NewtonOrganisationUS National Cancer InstituteEurope's pharma groups change product mix
Interviewee/ContributorRobin DavisonOrganisationNew Science Global Healthcare FundBuilding capacity in Europe for cell and gene therapy
Interviewee/ContributorYasmin de Faria KrimOrganisationIndependent regulatory affairs professionalRecord equity financing in 2018 for ATMPs
Interviewee/ContributorWilliam EllingtonOrganisationMedNousWill gene editing unmask synthetic lethal targets?
Interviewee/ContributorCeri Wiggins and Jon MooreOrganisationHorizon Discovery Group PlcHow gene editing is changing the field of medicine
Interviewee/ContributorPeter CharlishOrganisationMedNousThe need for innovation in neuroscience
Interviewee/ContributorJean-Claude MullerOrganisationMedNous